Annual CFF
$46.22 M
-$57.04 M-55.24%
December 31, 2023
Summary
- As of February 7, 2025, OBIO annual cash flow from financing activities is $46.22 million, with the most recent change of -$57.04 million (-55.24%) on December 31, 2023.
- During the last 3 years, OBIO annual CFF has risen by +$36.22 million (+362.15%).
- OBIO annual CFF is now -55.24% below its all-time high of $103.26 million, reached on December 31, 2022.
Performance
OBIO Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$15.04 M
+$14.86 M+8692.40%
September 30, 2024
Summary
- As of February 7, 2025, OBIO quarterly cash flow from financing activities is $15.04 million, with the most recent change of +$14.86 million (+8692.40%) on September 30, 2024.
- Over the past year, OBIO quarterly CFF has increased by +$15.03 million (+375775.00%).
- OBIO quarterly CFF is now -82.53% below its all-time high of $86.08 million, reached on June 30, 2022.
Performance
OBIO Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$4.53 M
+$15.03 M+143.11%
September 30, 2024
Summary
- As of February 7, 2025, OBIO TTM cash flow from financing activities is $4.53 million, with the most recent change of +$15.03 million (+143.11%) on September 30, 2024.
- Over the past year, OBIO TTM CFF has dropped by -$47.29 million (-91.26%).
- OBIO TTM CFF is now -96.65% below its all-time high of $135.31 million, reached on March 31, 2023.
Performance
OBIO TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
OBIO Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -55.2% | +10000.0% | -91.3% |
| 3 y3 years | +362.1% | +395.4% | -95.6% |
| 5 y5 years | +362.1% | +395.4% | -95.6% |
OBIO Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -55.2% | +1257.4% | -82.5% | +240.6% | -96.7% | +142.8% |
| 5 y | 5-year | -55.2% | +1257.4% | -82.5% | +240.6% | -96.7% | +142.8% |
| alltime | all time | -55.2% | +1257.4% | -82.5% | +240.6% | -96.7% | +142.8% |
Orchestra BioMed Holdings Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $15.04 M(+8692.4%) | $4.53 M(-143.1%) |
| Jun 2024 | - | $171.00 K(+850.0%) | -$10.50 M(-0.8%) |
| Mar 2024 | - | $18.00 K(-100.2%) | -$10.59 M(-122.9%) |
| Dec 2023 | $46.22 M | -$10.70 M(<-9900.0%) | $46.22 M(-10.8%) |
| Sep 2023 | - | $4000.00(-95.3%) | $51.82 M(+5.1%) |
| Jun 2023 | - | $86.00 K(-99.8%) | $49.32 M(-63.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2023 | - | $56.82 M(-1216.3%) | $135.31 M(+31.0%) |
| Dec 2022 | $103.26 M(-2686.0%) | -$5.09 M(+103.8%) | $103.26 M(-4.7%) |
| Sep 2022 | - | -$2.50 M(-102.9%) | $108.35 M(-2.3%) |
| Jun 2022 | - | $86.08 M(+247.6%) | $110.84 M(+347.6%) |
| Mar 2022 | - | $24.76 M | $24.76 M |
| Dec 2021 | -$3.99 M(-139.9%) | - | - |
| Dec 2020 | $10.00 M | - | - |
FAQ
- What is Orchestra BioMed Holdings annual cash flow from financing activities?
- What is the all time high annual CFF for Orchestra BioMed Holdings?
- What is Orchestra BioMed Holdings annual CFF year-on-year change?
- What is Orchestra BioMed Holdings quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Orchestra BioMed Holdings?
- What is Orchestra BioMed Holdings quarterly CFF year-on-year change?
- What is Orchestra BioMed Holdings TTM cash flow from financing activities?
- What is the all time high TTM CFF for Orchestra BioMed Holdings?
- What is Orchestra BioMed Holdings TTM CFF year-on-year change?
What is Orchestra BioMed Holdings annual cash flow from financing activities?
The current annual CFF of OBIO is $46.22 M
What is the all time high annual CFF for Orchestra BioMed Holdings?
Orchestra BioMed Holdings all-time high annual cash flow from financing activities is $103.26 M
What is Orchestra BioMed Holdings annual CFF year-on-year change?
Over the past year, OBIO annual cash flow from financing activities has changed by -$57.04 M (-55.24%)
What is Orchestra BioMed Holdings quarterly cash flow from financing activities?
The current quarterly CFF of OBIO is $15.04 M
What is the all time high quarterly CFF for Orchestra BioMed Holdings?
Orchestra BioMed Holdings all-time high quarterly cash flow from financing activities is $86.08 M
What is Orchestra BioMed Holdings quarterly CFF year-on-year change?
Over the past year, OBIO quarterly cash flow from financing activities has changed by +$15.03 M (+375775.00%)
What is Orchestra BioMed Holdings TTM cash flow from financing activities?
The current TTM CFF of OBIO is $4.53 M
What is the all time high TTM CFF for Orchestra BioMed Holdings?
Orchestra BioMed Holdings all-time high TTM cash flow from financing activities is $135.31 M
What is Orchestra BioMed Holdings TTM CFF year-on-year change?
Over the past year, OBIO TTM cash flow from financing activities has changed by -$47.29 M (-91.26%)